Pfizer (NEOE:ZPFE) Cyclically Adjusted FCF per Share: C$1.18 (As of Mar. 2026)


NEOE:ZPFE Pfizer Inc NEOE:ZPFE
57 GF Score
Price C$9.51
GF Value C$10.29
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Pfizer Cyclically Adjusted FCF per Share?

Pfizer NEOE:ZPFE 57 Cyclically Adjusted FCF per Share is C$1.18 as of Mar. 2026. GuruFocus rates NEOE:ZPFE with a GF Score™ of 57/100 and a GF Value™ of C$10.29 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Pfizer's adjusted free cash flow per share for the three months ended in Mar. 2026 was C$0.522. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is C$1.18 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Pfizer's average Cyclically Adjusted FCF Growth Rate was -1.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -2.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 3.50% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Pfizer was 29.20% per year. The lowest was -2.40% per year. And the median was 8.50% per year.

As of today (2026-07-09), Pfizer's current stock price is C$9.51. Pfizer's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was C$1.18. Pfizer's Cyclically Adjusted Price-to-FCF of today is 8.06.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pfizer was 21.47. The lowest was 7.09. And the median was 14.31.


Pfizer  (NEOE:ZPFE) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Pfizer's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=9.51/1.18
=8.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pfizer was 21.47. The lowest was 7.09. And the median was 14.31.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Pfizer Cyclically Adjusted FCF per Share Related Terms


Pfizer Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Pfizer's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Cyclically Adjusted FCF per Share Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.20

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 1.20 1.18

NEOE:ZPFE vs GILD, BMY, AMGN: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, Pfizer's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pfizer's Cyclically Adjusted Price-to-FCF falls into.


NEOE:ZPFE
57GF Score
Pfizer Inc NEOE:ZPFE
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pfizer's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.522/330.2130*330.2130
=0.522

Current CPI (Mar. 2026) = 330.2130.

Pfizer Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.652 241.018 0.893
201609 0.918 241.428 1.256
201612 1.151 241.432 1.574
201703 0.269 243.801 0.364
201706 0.606 244.955 0.817
201709 0.872 246.819 1.167
201712 1.331 246.524 1.783
201803 0.334 249.554 0.442
201806 0.755 251.989 0.989
201809 1.023 252.439 1.338
201812 0.910 251.233 1.196
201903 0.251 254.202 0.326
201906 0.474 256.143 0.611
201909 0.902 256.759 1.160
201912 0.840 256.974 1.079
202003 0.668 258.115 0.855
202006 0.747 257.797 0.957
202009 0.372 260.280 0.472
202012 1.089 260.474 1.381
202103 0.884 264.877 1.102
202106 2.316 271.696 2.815
202109 2.260 274.310 2.721
202112 1.090 278.802 1.291
202203 1.297 287.504 1.490
202206 1.663 296.311 1.853
202209 1.197 296.808 1.332
202212 1.793 296.797 1.995
202303 0.017 301.836 0.019
202306 -0.493 305.109 -0.534
202309 0.634 307.789 0.680
202312 0.989 306.746 1.065
202403 0.092 312.332 0.097
202406 -0.582 314.175 -0.612
202409 1.440 315.301 1.508
202412 1.450 315.605 1.517
202503 0.445 319.799 0.459
202506 -0.287 322.561 -0.294
202509 0.969 324.800 0.985
202512 1.086 324.054 1.107
202603 0.522 330.213 0.522

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of C$1.18 mean?
Pfizer (NEOE:ZPFE) has a Cyclically Adjusted FCF per Share of C$1.18 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Pfizer and its competitors.
Is Pfizer's Cyclically Adjusted FCF per Share too high?
Pfizer's current Cyclically Adjusted FCF per Share is C$1.18. Overall, Pfizer has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Cyclically Adjusted FCF per Share compare to GILD and BMY?
Pfizer's Cyclically Adjusted FCF per Share of C$1.18 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Pfizer and its competitors. Pfizer's current Cyclically Adjusted FCF per Share is C$1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Based on GuruFocus' analysis, Pfizer (NEOE:ZPFE) is currently considered Fairly Valued. The stock's GF Value™ is C$10.29, compared to a current price of C$9.51 — trading 7.6% below its estimated fair value. The current Cyclically Adjusted FCF per Share is C$1.18. Pfizer's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Pfizer (NEOE:ZPFE), the current Cyclically Adjusted FCF per Share is C$1.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (NEOE:ZPFE) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of C$9.51 is trading 7.6% below its estimated GF Value™ of C$10.29. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for NEOE:ZPFE:

  • Cyclically Adjusted FCF per Share: C$1.18
  • GF Value™: C$10.29 vs. price of C$9.51 (7.6% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the NEOE:ZPFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
57GF Score

Get the complete analysis for NEOE:ZPFE

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$9.51
Price
C$10.29
GF Value